SCHEMBL5421815

SCHEMBL5421815

CC(C)(C)OC(=O)N1CCN(c2ccc(NC(=O)O)cc2F)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 1/20 0.55
F13A1 P00488 2/20 0.53
TGM2 P21980 2/20 0.53
TGM1 P22735 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
MAPT P10636 7/20 0.51
KDM4E B2RXH2 1/20 0.51
TSHR P16473 2/20 0.49
NPC1 O15118 2/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
NAMPT P43490 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7846281 0.91 F13A1 (0.53) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL8250828 0.91 F13A1 (0.53) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL8259530 0.88 NPY2R (0.56) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL4004656 0.88 F13A1 (0.50) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL8250825 0.88 L3MBTL1 (0.59) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL30063444 0.88 L3MBTL1 (0.59) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL13541839 0.85 KDM4E (0.57) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL4563571 0.85 MEN1 (0.60) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL8432787 0.85 F13A1 (0.51) NPY2RF13A1TGM2TGM1L3MBTL1
SCHEMBL4004710 0.85 NPY2R (0.60) NPY2RKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167414-A1 Novel antibacterial agents ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2007-07-19 US disclosed
US-7217726-B2 Antibacterial agents ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2007-05-15 US disclosed
EP-1578734-A1 NOVEL ANTIBACTERIAL AGENTS Orchid Chemicals and Pharmaceuticals Ltd (IN) 2005-09-28 EP disclosed
US-20050070526-A1 Novel antibacterial agents ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2005-03-31 US disclosed
WO-2004018439-A1 NOVEL ANTIBACTERIAL AGENTS ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167414-A1 Novel antibacterial agents TBCD, OXA1L, ALPI NPY2R 3312/4885F13A1 4564/4885TGM2 1612/4885
US-20050070526-A1 Novel antibacterial agents TBCD, OXA1L, ALPI NPY2R 3312/4885F13A1 4564/4885TGM2 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.